Dopamine Receptor DRD2 Gene rs1076560, Personality Traits and Anxiety in the Polysubstance Use Disorder.
Aleksandra SuchaneckaJolanta ChmielowiecKrzysztof ChmielowiecJolanta MasiakOlimpia Sipak-SzmigielMariusz SznabowiczWojciech CzarnyMonika Michałowska-SawczynGrzegorz TrybekAnna GrzywaczPublished in: Brain sciences (2020)
Development of an addiction is conditioned by many factors. The dopaminergic system has been shown to be the key element in this process. In this paper, we analyzed the influence of dopamine receptor 2 polymorphism rs1076560 in two groups-polysubstance-dependent male patients (n = 299) and the controls matched for age (n = 301). In both groups, we applied the same questionnaires for testing-Mini-international neuropsychiatric interview, the NEO Five-Factor Inventory, and the State-Trait Anxiety Inventory. The real-time PCR method was used for genotyping. When we compared the controls with the case group subjects, we observed significantly higher scores in the second group on both the state and trait scales of anxiety, as well as on the Neuroticism and Openness scales of the NEO-FFI; and lower scores on the scales of Extraversion and Agreeability of the NEO-FFI. The model 2×3 factorial ANOVA of the addicted subjects and controls was performed, and the DRD2 rs1076560 variant interaction was found for the anxiety state and trait scales, and for the NEO-FFI Neuroticism scale. The observed associations allow noticing that analysis of psychological factors in combination with genetic data opens new possibilities in addiction research.
Keyphrases
- genome wide
- sleep quality
- end stage renal disease
- dna methylation
- real time pcr
- ejection fraction
- copy number
- chronic kidney disease
- newly diagnosed
- uric acid
- prognostic factors
- electronic health record
- physical activity
- gene expression
- machine learning
- psychometric properties
- big data
- metabolic syndrome
- single cell
- binding protein
- deep learning